Ignite Creation Date:
2024-05-06 @ 1:11 PM
Last Modification Date:
2024-10-26 @ 1:10 PM
Study NCT ID:
NCT03952325
Status:
TERMINATED
Last Update Posted:
2021-07-30
First Post:
2019-05-14
Brief Title:
Tesetaxel Plus 3 Different PD-L1 Inhibitors in Patients With Triple-Negative MBC and Tesetaxel Monotherapy in Patients With HER2-Negative MBC
Sponsor:
Organization:
Odonate Therapeutics Inc